Navigation Links
Micromet, Inc. Reports First Quarter 2009 Financial Results

ndidates may be discovered upon further analysis of preclinical or clinical trial data, the risk that we or our collaborators will not obtain approval to market our product candidates, the risks associated with reliance on outside financing to meet capital requirements, and the risks associated with reliance on collaborators, including MedImmune, Merck Serono, TRACON and Nycomed, for the funding or conduct of further development and commercialization activities relating to our product candidates. These factors and others are more fully discussed in Micromet's Annual Report on Form 10-K for the year ended December 31, 2008, filed with the SEC on March 16, 2009, as well as other filings by the company with the SEC.

                                  (Tables Follow)

                                  Micromet, Inc.
                      Condensed Consolidated Balance Sheets
                         (In thousands, except par value)

                                                       March 31,  December 31,
                                                         2009          2008
    Current assets:
    Cash, cash equivalents and short-term investments   $45,123       $46,168
        Accounts receivable                               5,805         3,424
        Prepaid expenses and other current assets         1,297         1,950
    Total current assets                                 52,225        51,542
    Property and equipment, net                           3,102         3,322
    Goodwill                                              6,462         6,462
    Patents, net                                          4,427         5,250
    Other long-term assets                                  958           959
    Long-term investments                                 2,006             -
    Restricted cash                                       3
SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Micromet, Inc. Reports First Quarter 2008 Financial Results
2. Micromet, Inc. Reports Second Quarter 2008 Financial Results
3. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented at American Society of Hematology Annual Meeting
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. Haemacure Reports Third Quarter 2007 Results
6. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
7. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
8. MDS Reports Third Quarter 2007 Results
9. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Post Your Comments:
(Date:10/9/2015)... ... October 09, 2015 , ... Prescription ... from all walks of life to save money on the high cost of ... per month per medication, individuals and families can receive their medications delivered direct ...
(Date:10/9/2015)... ... October 09, 2015 , ... Deadly, record-smashing rainfall has ... Foundation (CCCF) in Columbia, South Carolina. In response, the Foundation has established a ... – both short and long term. 100% of monies donated will go directly ...
(Date:10/9/2015)... ... , ... A variety of race options will be available for the Run 4 Recovery sponsored ... at Al Lopez Park, 4810 North Himes Avenue, in Tampa. The family friendly event will ... run or walk and a one-mile walk, followed by an award ceremony at 10 a.m. ...
(Date:10/9/2015)... ... October 09, 2015 , ... When the producers of the popular ‘Ask This ... in West Hollywood, CA, they turned to a trusted resource in Tamarack Technologies. , ... bungalow, and because of our successful past experience with the show they enlisted our ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... In the ... bombs that often did not explode. A very brave group of men were ... Kingdom. As Winston Churchill noted in 1941, “The rapid disposal of unexploded bombs is ...
Breaking Medicine News(10 mins):
... diagnoses are taken into consideration, patients undergoing colon surgery ... procedure is performed at a teaching hospital, according to ... of Surgery, one of the JAMA/Archives journals. ... fellows in the United States, which requires a considerable ...
... Study finds 3 percent of those who get something lodged ... -- Although the number of young children who choke after ... death when that happens is real, the latest research indicates. ... said study author Dr. Rahul K. Shah, a pediatric otolaryngologist ...
... A new grant from the Office of Naval Research ... College of Engineering professors and their collaborators from Indiana ... analyzing data. Such methods could potentially serve as tools ... grant will provide funding to develop computer programs capable ...
... Findings could explain rise in non-smokers as well, researchers say ... mice report they,ve gained insight into why lung cancer rates ... , In a new study, they say they,ve found that ... female mice. This, in turn, appears to affect the body,s ...
... ... Medical Institute in Mesa, which offers respiratory therapy career training and several other health ... efforts surrounding the Phoenix Asthma Walk. The annual fundraising walk took place on Saturday, ... ...
... ... or personal use, announces the release of their 2010 Spring All Occasions Greeting Cards Catalog. ... a catalog mailed to you or to access the virtual edition, visit , ... Plano, TX ((PRWEB) April 19, 2010 ...
Cached Medicine News:
(Date:10/9/2015)... 2015 Adheron Therapeutics, a privately held ... , United States , ... acquired by Roche.  Adheron Therapeutics has developed a ... a cell surface protein called Cadherin-11 in order ... inflammatory and autoimmune diseases such as rheumatoid arthritis ...
(Date:10/9/2015)... , Suiza, October 9, 2015 El ,JCA-Mauvernay ... Yutaka Kondo y Junko Takita    ... otorgado a los doctores Yutaka Kondo y ... ,JCA-Mauvernay Award 2015, se ha otorgado a los doctores ...    ™ , una compañía biofarmacéutica global con sede enSuiza, ...
(Date:10/8/2015)... 2015 Johnson & Johnson (NYSE: JNJ ) ... trial in Sierra Leone of a ... Companies. Trial recruitment is underway, and the first volunteers have ... conducted of Janssen,s Ebola prime-boost vaccine regimen in a West ... Sierra Leone,s Kambia district, where some of ...
Breaking Medicine Technology:
... ChemoCentryx, Inc. (NASDAQ: CCXI) announced today the pricing of ... common stock at $10.00 per share, before underwriting discounts ... offered by ChemoCentryx. In addition, the underwriters have a ... shares of common stock from ChemoCentryx to cover over-allotments, ...
... Company (Nasdaq: PRGO;TASE) today announced that Perrigo CFO ... 2012 Global Healthcare Conference on Wednesday, February 15th, ... in New York.   Perrigo Company ... manufactures and distributes OTC and generic prescription (Rx) ...
Cached Medicine Technology:
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: